Pharmaron Beijing Co Ltd
SZSE:300759
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
CN |
|
National Bank of Canada
TSX:NA
|
CA |
|
F
|
Flow Traders NV
LSE:0R96
|
NL |
|
Unisys Corp
NYSE:UIS
|
US |
|
Saudi Arabian Mining Company SJSC
SAU:1211
|
SA |
|
Solid Power Inc
NASDAQ:SLDP
|
US |
Wall Street
Price Targets
Price Targets Summary
Pharmaron Beijing Co Ltd
According to Wall Street analysts, the average 1-year price target for
Pharmaron Beijing Co Ltd
is 38.38 CNY
with a low forecast of 25.55 CNY and a high forecast of 46 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Pharmaron Beijing Co Ltd's stock price target?
Price Target
38.38
CNY
According to Wall Street analysts, the average 1-year price target for
Pharmaron Beijing Co Ltd
is 38.38 CNY
with a low forecast of 25.55 CNY and a high forecast of 46 CNY.
What is Pharmaron Beijing Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Pharmaron Beijing Co Ltd's revenue is
29%.
The projected
CAGR
for the next 3 years is
15%.
What is Pharmaron Beijing Co Ltd's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Pharmaron Beijing Co Ltd's operating income is
33%.
The projected
CAGR
for the next 3 years is
21%.
What is Pharmaron Beijing Co Ltd's Net Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Pharmaron Beijing Co Ltd's net income is
34%.
The projected
CAGR
for the next 3 years is
13%.
